David A. Siegel Immunome Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Immunome Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 48,200 shares of IMNM stock, worth $510,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,200Holding current value
$510,920% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
124Shares Held
45.4MCall Options Held
38.7KPut Options Held
2.05M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.5MShares$58.3 Million0.04% of portfolio
-
Redmile Group, LLC San Francisco, CA4.83MShares$51.2 Million3.87% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$41.1 Million1.86% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$39.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.46MShares$36.6 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $129M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...